Edwards Lifesciences · Operating Cash Flow (Statement)

Latest reported$1.72Bperiod endingJun 30, 2026

EW Cash from Operations ($176.00M → $1.72B)

Annual operating cash flow (statement)

High-resolution chart · PNG

EW operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	1,595,200,000
Dec 31, 2024	542,300,000
Dec 31, 2023	895,800,000
Dec 31, 2022	1,218,200,000
Dec 31, 2021	1,732,100,000
Dec 31, 2020	1,054,300,000
Dec 31, 2019	1,179,400,000
Dec 31, 2018	926,800,000
Dec 31, 2017	1,000,700,000
Dec 31, 2016	704,400,000
Dec 31, 2015	549,700,000
Dec 31, 2014	1,022,300,000
Dec 31, 2013	472,700,000
Dec 31, 2012	373,800,000
Dec 31, 2011	314,500,000
Dec 31, 2010	251,400,000
Dec 31, 2009	165,300,000
Dec 31, 2008	153,200,000
Dec 31, 2007	210,200,000
Dec 31, 2006	230,800,000
Dec 31, 2005	136,800,000
Dec 31, 2004	180,600,000
Dec 31, 2003	122,300,000
Dec 31, 2002	120,600,000
Dec 31, 2001	101,000,000
Dec 31, 2000	137,000,000
Dec 31, 1999	176,000,000